EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Broad-Spectrum Antiviral Evaluation of Novel 1,2,3-Triazole–Quinoline Derivatives Targeting SARS-CoV-2, Influenza, DENV-2, and CHIKV

Alcione Silva de Carvalho, Natalia Fintelman-Rodrigues iD, Victória Toledo Diniz de Camargo, Lina Silva-Trujillo iD, Caroline Souza de Freitas iD, Isabela Alencar Graciano, Acácio Silva de Souza, Camilla Blanco de Assis iD, Otávio Augusto Chaves iD, Fernando de Carvalho da Silva iD, Vitor F Ferreira iD, Thiago Moreno L Souza

Viruses · 2026

DOI: 10.3390/v18090951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Alcione Silva de Carvalho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências Aplicadas a Produtos para a Saúde, Faculdade de Farmácia, Universidade Federal Fluminense, Niterói 24241-000, R…. Hauptthemen laut MEDLINE: Antiviral Agents, Triazoles, Quinolines, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brazilian Federal Agency for Support and Evaluation of Graduate Education, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistent global threat posed by emerging and re-emerging RNA viruses, including SARS-CoV-2, influenza A(H1N1)pdm09, DENV-2, and CHIKV, highlights the critical need for novel and broad-spectrum antiviral agents. Building upon the established antiviral activity of the quinoline scaffold, this study employed a molecular hybridization strategy to design and synthesize a novel series of 1,2,3-triazole–quinoline derivatives (compounds 4a–4h). This approach strategically fused the bioactive quinoline nucleus with the pharmaceutically favorable 1,2,3-triazole ring. The new compounds were synthesized efficiently in three steps with moderate-to-high yields, and their structures were subsequently determined. Their inhibitory capacities against the four viruses and cytotoxicity across relevant cell lines were evaluated in vitro. The initial screening demonstrated that compounds 4a–4h possessed broad-spectrum antiviral activity, showing high inhibition percentages at 10 µM against SARS-CoV-2, DENV-2, and CHIKV. Notably, compounds 4c and 4e, substituted with methoxy and ethyl groups, respectively, displayed exceptional potency and safety against SARS-CoV-2, yielding high selectivity indices (SI: 1896.5 and 1265.8, respectively). Furthermore, in silico absorption, distribution, metabolism, and excretion (ADME) and molecular docking calculations suggested favorable drug-likeness profiles, including improved lipophilicity and non-P-glycoprotein substrate feasibility. The findings validate the molecular hybridization strategy, establishing this new class of compounds as promising, multi-target antiviral prototypes for further preclinical exploration against prevalent viral pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsTriazolesQuinolinesSARS-CoV-2Chikungunya virusDengue VirusHumansAnimalsMolecular Docking SimulationCell LineInfluenza A Virus, H1N1 Subtype

Stichwörter der Autor:innen

antiviral discoverybroad-spectrum antiviral agentsmolecular hybridization

Substanzen

Antiviral AgentsTriazolesQuinolines

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Ciências Aplicadas a Produtos para a Saúde, Faculdade de Farmácia, Universidade Federal Fluminense, Niterói 24241-000, RJ, Brazil.
  • Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in COVID-19 and Health Emergencies, Oswaldo Cruz Institute, Rio de Janeiro 21040-361, RJ, Brazil.
  • Center for Technological Development in Health, National Institute for Science and Technology on Innovation on Neglected Diseases and Neglected Populations, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
  • Laboratory of Viral Diseases Immunology, René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, MG, Brazil.
  • Applied Molecular Chemistry Laboratory (LaQMA), Department of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities and Exact Sciences (IBILCE), São Paulo State University (UNESP), São José do Rio P…
  • Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Niterói 24020-141, RJ, Brazil.

ORCID-Profile: Natalia Fintelman-Rodrigues, Lina Silva-Trujillo, Caroline Souza de Freitas, Camilla Blanco de Assis, Otávio Augusto Chaves, Fernando de Carvalho da Silva, Vitor F Ferreira

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Brazilian Federal Agency for Support and Evaluation of Graduate Education
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • The Brazilian agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil
  • National Institutes of Science and Technology Program (INCT) on Diseases of Neglected Populations

Zitieren

APA

de Carvalho, A. S., Fintelman-Rodrigues, N., de Camargo, V. T. D., Silva-Trujillo, L., de Freitas, C. S., Graciano, I. A., de Souza, A. S., de Assis, C. B., Chaves, O. A., da Silva, F. C., Ferreira, V. F., & Souza, T. M. L. (2026). Synthesis and Broad-Spectrum Antiviral Evaluation of Novel 1,2,3-Triazole–Quinoline Derivatives Targeting SARS-CoV-2, Influenza, DENV-2, and CHIKV. Viruses. https://doi.org/10.3390/v18090951

Vancouver

de Carvalho AS, Fintelman-Rodrigues N, de Camargo VTD, Silva-Trujillo L, de Freitas CS, Graciano IA, et al. Synthesis and Broad-Spectrum Antiviral Evaluation of Novel 1,2,3-Triazole–Quinoline Derivatives Targeting SARS-CoV-2, Influenza, DENV-2, and CHIKV. Viruses. 2026. doi:10.3390/v18090951

BibTeX
@article{deCarvalho2026,
  author = {de Carvalho, Alcione Silva and Fintelman-Rodrigues, Natalia and de Camargo, Victória Toledo Diniz and Silva-Trujillo, Lina and de Freitas, Caroline Souza and Graciano, Isabela Alencar and de Souza, Acácio Silva and de Assis, Camilla Blanco and Chaves, Otávio Augusto and da Silva, Fernando de Carvalho and Ferreira, Vitor F and Souza, Thiago Moreno L},
  title = {Synthesis and Broad-Spectrum Antiviral Evaluation of Novel 1,2,3-Triazole–Quinoline Derivatives Targeting SARS-CoV-2, Influenza, DENV-2, and CHIKV},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18090951}
}
Kostenlos starten →